BioSpace News Archive

Moberg Pharma AB have submitted its marketing authorization application for MOB-015.

The global airway management devices are medical devices used for patients have obstructed airways or are at the risk of being obstructed.

The demand within the global opioid withdrawal treatment market is rising as a large population of people falls victim to the ills of drug abuse.

The global medical connectors market offers a range of products including hybrid receptacle system and circular connectors, disposable plastic connectors, radiofrequency connectors, embedded electronics connectors, and flat surgical silicone cables.

The global market for infertility treatment has been expanding on account of rising awareness quotient of the masses across the globe.

Frankincense is a tree gum that has been utilized and esteemed since antiquated occasions for its restorative, corrective, fragrant and otherworldly applications.

Optical biometry devices are used for intraocular lens power calculations in clinical practice. Optical biometry is very accurate and non-invasive automated procedure that measures the characteristics of the eyes automatically.

NRx Pharmaceuticals, Inc., a clinical-stage, biopharmaceutical company announced that management will report year end 2021 financial results prior to the market open on March 31, 2022.

Taiho Pharmaceutical Co., Ltd. and Helsinn Group, announced that Taiho has been granted approval from the Japanese Ministry of Health, Labour and Welfare to manufacture and market the NK1 receptor antagonist antiemetic drug “Arokaris® I.V. Infusion 235mg” for gastrointestinal symptoms associated with cancer chemotherapy.

Eagle Pharmaceuticals, Inc. announced it has reached agreement on the terms of a transfer of the entire issued and to be issued share capital of Acacia Pharma Group plc to Eagle by way of a scheme of arrangement under Part 26 of the United Kingdom’s Companies Act 2006.